Skip to content
Resources > Webinars & Videos

Ready for Q2? Maximise Your Deal Flow with AlphaSense

March 1, 2026
About the Speakers
  • Daren Yoong

    APAC Head of Enterprise Sales - Life Sciences, AlphaSense
  • Pak Teng Chow

    Senior Account Executive, Life Sciences, AlphaSense

Please fill in the form above to load the video!

Watch this tactical "before you go" session that equips Business Development & Licensing leaders with strategies to cut through the noise using real-time market intelligence—so you can identify precisely who to engage, which therapeutic areas or assets to prioritize, and where untapped licensing or collaboration opportunities lie. You'll discover how to pinpoint high-intent investors, strategic partners, and potential licensors, streamline your due diligence, and enter every interaction armed with actionable insights to accelerate productive negotiations and close deals faster.

You'll learn how to:

  • Build a high-priority target list of investors, partners, and licensing prospects using live market signals
  • Generate detailed investor, company, and asset profiles in minutes, tailored to your therapeutic focus
  • Detect competitor licensing moves, M&A activity, and emerging deal flow ahead of the curve
  • Set real-time alerts on pipeline developments, regulatory shifts, and market trends to maintain an edge during events or ongoing scouting

Watch it now to unlock efficient workflows for pre-event prep, routine market landscaping, and proactive deal discovery in the Life Sciences sector.

Explore more

AlphaSense: YH2’s Edge in AI-Powered Investment Research

Learn how YH2 transformed its investment research process with AlphaSense, delivering speed and knowledge sharing to drive conviction.
AlphaSense: YH2’s Edge in AI-Powered Investment Research

From Signals to Strategy: Tracking Emerging Trends in Public and Private Markets Through Workflow Automation

Natasa Motwani, head of VC and emerging tech coverage at UBS, discusses the journey that helped shape her approach as a key industry AI adopter.
From Signals to Strategy

Healthcare 2026 Industry Outlook: A Year of Necessary Transformation

The pressures of 2025 suggest that in 2026 the healthcare industry will need to shift toward structural changes that ensure long-term prosperity.
Title slide: "Healthcare 2026 Industry Outlook: A Year of Necessary Transformation" by Sara Mallatt, featuring illustrations of a split pill, microscope, and medical cross.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.